World's Best Scientists 2026 revealed!
Angelo Avogaro

Angelo Avogaro

D-Index & Metrics

Medicine

D-Index
107
Citations
37244
World Ranking
6321
National Ranking
201

Angelo Avogaro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Angelo Avogaro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 709 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Angelo Avogaro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Angelo Avogaro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Angelo Avogaro is affiliated with the University of Padua in Italy and has a significant research footprint primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly contributions focus extensively on Endocrinology, Diabetes and Metabolism, alongside subfields such as Molecular Biology, Surgery, Genetics, and Epidemiology.

The scientist's work centers around topics related to diabetes, including treatment and management, research in diabetes management, metabolic interactions between diabetes and cancer, pancreatic function, diabetes-associated disorders, and the clinical research of COVID-19. Their research also covers the interplay between diabetes, cardiovascular risks, and lipoproteins.

Notable recent papers authored include:

  • Prevalence and impact of diabetes among people infected with SARS-CoV-2, 2020, Journal of Endocrinological Investigation
  • Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration, 2020, Diabetes Research and Clinical Practice
  • Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy, 2020, Diabetes Therapy
  • Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence, 2020, Diabetes Metabolic Syndrome and Obesity
  • Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people with type 2 diabetes: A case-control study, 2020, Diabetes Obesity and Metabolism

Angelo Avogaro has published extensively across various journals, with the most frequent publication venues including:

  • Journal of Endocrinological Investigation
  • Cardiovascular Diabetology
  • Diabetes Obesity and Metabolism
  • Acta Diabetologica
  • Diabetes Research and Clinical Practice

Collaboration is a significant aspect of this scientist's work. Frequent co-authors include:

  • Gian Paolo Fadini
  • Mario Luca Morieri
  • Benedetta Maria Bonora
  • Agostino Consoli
  • Enrico Longato

Throughout their career, Angelo Avogaro has contributed to advancing knowledge in diabetes treatment and management by examining various aspects such as glycemic control, the impact of diabetes on COVID-19 severity, and the extraglycemic effects of diabetes medications. The scientist's multidisciplinary expertise integrates molecular biology and clinical insights to explore complex interactions in metabolic diseases.

Best Publications

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes Mellitus

    Gian Paolo Fadini;Marta Miorin;Monica Facco;Sondra Bonamico

  • Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes.

    Roldano Scognamiglio;Angelo Avogaro;Saula Vigili de Kreutzenberg;Christian Negut

  • Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms

    Angelo Avogaro;Mattia Albiero;Lisa Menegazzo;Saula de Kreutzenberg

  • Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy

    Gian Paolo Fadini;Saverio Sartore;Mattia Albiero;Ilenia Baesso

  • Prevalence and impact of diabetes among people infected with SARS-CoV-2.

    G. P. Fadini;M. L. Morieri;E. Longato;A. Avogaro

  • The Oral Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Increases Circulating Endothelial Progenitor Cells in Patients With Type 2 Diabetes: Possible role of stromal-derived factor-1α

    Gian Paolo Fadini;Elisa Boscaro;Mattia Albiero;Lisa Menegazzo

  • Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure

    Alessandra Dei Cas;Sadiya S. Khan;Javed Butler;Robert J. Mentz

  • Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia

    Marc Breton;Anne Farret;Daniela Bruttomesso;Stacey Anderson

  • Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature.

    Gian Paolo Fadini;Carlo Agostini;Angelo Avogaro

  • Downregulation of the Longevity-Associated Protein Sirtuin 1 in Insulin Resistance and Metabolic Syndrome: Potential Biochemical Mechanisms

    Saula Vigili de Kreutzenberg;Giulio Ceolotto;Italia Papparella;Alessia Bortoluzzi

  • Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.

    Gian Paolo Fadini;Ilenia Baesso;Mattia Albiero;Saverio Sartore

  • Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats.

    Gian Paolo Fadini;Saverio Sartore;Marco Schiavon;Mattia Albiero

  • Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus.

    Roldano Scognamiglio;Christian Negut;Angelo Ramondo;Antonio Tiengo

  • Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk.

    Gian Paolo Fadini;Saula Vigili de Kreutzenberg;Anna Coracina;Ilenia Baesso

  • NETosis Delays Diabetic Wound Healing in Mice and Humans

    Gian Paolo Fadini;Lisa Menegazzo;Mauro Rigato;Valentina Scattolini

  • Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

    Olga Vaccaro;Maria Masulli;Antonio Nicolucci;Enzo Bonora

  • Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population.

    Gian Paolo Fadini;Anna Coracina;Ilenia Baesso;Carlo Agostini

  • 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

    F Cosentino;P J Grant;V Aboyans;C J Bailey

  • Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism

    Giulio Ceolotto;Alessandra Gallo;Italia Papparella;Lorenzo Franco

Frequent Co-Authors

Gian Paolo Fadini
Gian Paolo Fadini University of Padua
Claudio Cobelli
Claudio Cobelli University of Padua
Carlo Agostini
Carlo Agostini University of Padua
Lalo Magni
Lalo Magni University of Pavia
Giovanni Sparacino
Giovanni Sparacino University of Padua
Enzo Bonora
Enzo Bonora University of Verona
Gaetano Crepaldi
Gaetano Crepaldi University of Padua
Roberto Vettor
Roberto Vettor University of Padua
Giorgio Sesti
Giorgio Sesti Sapienza University of Rome
Andrea Facchinetti
Andrea Facchinetti University of Padua

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative educational pathways is essential for students interested in healthcare careers in the USA. For those seeking advanced practice roles, the 1 year dnp program online route offers a fast-track to a Doctor of Nursing Practice degree, helping working professionals gain leadership credentials quickly.

Not everyone is ready to commit to a long medical degree upfront. Programs like lpn programs provide an accessible entry point into nursing, preparing students for licensure and practical patient care roles in a short timeframe.

For those drawn to mental health services, accelerated msn psychiatric np programs allow graduates to specialize as psychiatric nurse practitioners, a field seeing rapid growth and demand nationwide.

Interested in healthcare operations rather than clinical care? A bachelors in health administration is an excellent choice, opening doors to management and administrative careers within hospitals, clinics, and public health organizations.

Best Scientists Citing Angelo Avogaro

Trending Scientists